Raphael, G., Taveras, H., Iverson, H., O’Brien, C., & Miller, D. (2016). Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma. J Asthma.
Chicago Style CitationRaphael, Gordon, Herminia Taveras, Harald Iverson, Christopher O’Brien, i David Miller. "Twelve- and 52-week Safety of Albuterol Multidose Dry Powder Inhaler in Patients With Persistent Asthma." J Asthma 2016.
Cita MLARaphael, Gordon, et al. "Twelve- and 52-week Safety of Albuterol Multidose Dry Powder Inhaler in Patients With Persistent Asthma." J Asthma 2016.
Atenció: Aquestes cites poden no estar 100% correctes.